drugset
drugset / Trial / NCT06931327

To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults

NCT06931327 ↗

Phase 1 Completed 60 enrolled AJU Pharm Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the safety and pharmacokinetic characteristics of AJU-C711 in healthy adults

Timeline

Start
2025-03-29
Primary completion
2025-04-16
Completion
2025-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject AJU-C711 Unknown — —
Subject C711R Unknown — —

Indications

hyperlipidemia